The Clinical Pain Advisor reviews a recent study in Pain Physician supporting the efficacy of an implanted peripheral nerve-stimulating device for chronic intractable headache. Although this device is not yet FDA approved, it may be a last-resort treatment for patients who have not had success using other types of therapy.
Evaluating for concussions, other sports-related injuries is imperative as student athletes head back to school and on to the playing field.
Researchers found significant associations between four genetic variants of SCN9A and neuropathic pain in DPN.
Many nerve entrapments fly ‘under the radar.’
As regulatory approval of medical marijuana spreads in the US, practicing clinicians need to be apprised of cannabis-related indications, efficacy, and adverse effects.
Feigned pain reports had significantly higher variability and poorer repeatability compared with sincere reports.
Clinicians managing and treating painful conditions in patients are facing a variety of challenges in the field. Bob Twillman, PhD, executive director of AAPM, sat down with CPA to discuss the details.